Latest News and Press Releases

TORONTO, Feb. 05, 2025 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in brain health technology and photobiomodulation (PBM), proudly announces the launch of the Neuro Pro 2, its most advanced...

Toronto, Canada, July 26, 2023 (GLOBE NEWSWIRE) -- Vielight Inc. announced it has commenced a new clinical trial in the United States to study how brain stimulation photobiomodulation (PBM)...

Toronto, Canada, July 13, 2023 (GLOBE NEWSWIRE) -- The United States Patent and Trademark Office (USPTO) on April 25, 2023, granted a utility patent to Dr. Lew Lim for his invention, “System and...

Toronto, Canada, June 14, 2023 (GLOBE NEWSWIRE) -- Update to Release on Globe Newswire from May 25, 2023 13:30 ET Vielight announced on Thursday, May 25, 2023 that its Vielight RX Plus device -...

Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...

Toronto, Canada, March 29, 2022 (GLOBE NEWSWIRE) -- Vielight Inc., a global leader in transcranial photobiomodulation (tPBM) research, development and manufacturing, is pleased to announce a new...

Toronto, Canada, Sept. 10, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of recruitment for a COVID-19 clinical trial in Ontario, Canada. This involves a home-use...

Toronto, Canada, Sept. 01, 2020 (GLOBE NEWSWIRE) -- Vielight Inc. is pleased to announce the commencement of a new clinical trial in the USA. In this trial, Vielight Inc. will test the hypothesis...

Toronto, Canada, June 04, 2019 (GLOBE NEWSWIRE) -- Vielight Inc. of Toronto, a leader in brain photobiomodulation (PBM) technology, announces that the primary site for its pivotal clinical trial,...